IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models
Janneke E. Jaspers(Memorial Sloan Kettering Cancer Center), Renier J. Brentjens(Roswell Park Comprehensive Cancer Center)
Cited by 165
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
|Nature Reviews Clinical Oncology|2019|1.4k
CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date
|Blood|2016|398
Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
|Scientific Reports|2017|397
GPRC5D-Targeted CAR T Cells for Myeloma
|New England Journal of Medicine|2022|383